HAE FY 2007 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2007 Earnings

Reported May 25, 2007

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$450M	—	$420M	—	7.1%
Op. Income	$63M	—	$99M	—	-36.6%
Gross Margin	50.6%	—	52.5%	—	-2.0pp
Net Margin	10.9%	—	16.5%	—	-5.5pp
EPS (Diluted)	$0.89	—	$1.25	—	-28.8%
Free Cash Flow	$42M	—	$49M	—	-13.8%

Revenue Flow

Item	Amount
REVENUE	$450M
Cost of Revenue	$222M
GROSS PROFIT	$227M
R&D Expenses	$24M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$137M
Other Expenses	-$5M
Operating Expenses	$155M
Cost & Expenses	$378M
OPERATING INCOME	$63M
Interest Income	$8M
Interest Expense	$97.0K
Other Income/Expenses	$10M
INCOME BEFORE TAX	$72M
Income Tax Expense	$23M
Net Income from Continuing Ops	$49M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$49M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$49M
D&A	$28M
EBIT	$72M
EBITDA	$101M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$450M
Cost of Revenue	$222M
GROSS PROFIT	$227M
R&D Expenses	$24M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$137M
Other Expenses	-$5M
Operating Expenses	$155M
Cost & Expenses	$378M
OPERATING INCOME	$63M
Interest Income	$8M
Interest Expense	$97.0K
Other Income/Expenses	$10M
INCOME BEFORE TAX	$72M
Income Tax Expense	$23M
Net Income from Continuing Ops	$49M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$49M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$49M
D&A	$28M
EBIT	$72M
EBITDA	$101M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$49M
Depreciation & Amortization	$28M
Stock-Based Compensation	$10M
Deferred Income Tax	$0
Other Non-Cash Items	$15M
Change in Working Capital	-$8M
OPERATING CASH FLOW	$84M
Capital Expenditure	-$41M
Acquisitions (Net)	-$33M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$3M
NET CASH FROM INVESTING	-$71M
Net Debt Issuance	-$10M
Common Stock Repurchased	-$40M
Common Dividends Paid	$0
Other Financing Activities	$0
NET CASH FROM FINANCING	-$36M
FREE CASH FLOW	$42M
Net Change in Cash	-$21M

Balance Sheet

Item	Amount
Cash & Equivalents	$229M
Short-Term Investments	$0
Net Receivables	$92M
Inventory	$62M
Other Current Assets	$21M
TOTAL CURRENT ASSETS	$404M
PP&E (Net)	$91M
Goodwill	$35M
Intangible Assets	$34M
Long-Term Investments	$0
Tax Assets	$5M
Other Non-Current Assets	$5M
TOTAL NON-CURRENT ASSETS	$169M
TOTAL ASSETS	$573M
Account Payables	$17M
Short-Term Debt	$22M
Deferred Revenue	$16M
Other Current Liabilities	$27M
TOTAL CURRENT LIABILITIES	$82M
Long-Term Debt	$7M
Deferred Revenue NC	-$5M
Deferred Tax Liabilities	$5M
Other Non-Current Liabilities	$4M
TOTAL NON-CURRENT LIABILITIES	$11M
TOTAL LIABILITIES	$93M
Common Stock	$265.0K
Additional Paid-In Capital	$164M
Retained Earnings	$316M
Treasury Stock	$0
Accum. Other Comp. Income	-$199.0K
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$480M
Minority Interest	$0
TOTAL EQUITY	$480M
TOTAL LIABILITIES & EQUITY	$573M
Total Debt	$29M
Net Debt	-$200M